Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia

References

• Romero R, Lockwood C, Oyarzun E, et al. Toxemia: new concepts in an old disease. Semin Perinatol 1988;12:302–323.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. The pathogenesis of pre-eclamp-sia. Gynecol Obstet Fertil 2001;29:518–522.
   PubMedGoogle Scholar
• Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998;179:1359–1375.
   PubMed Web of Science ®Google Scholar
• Roberts JM, Lain KY. Recent Insights into the pathogenesis of pre-eclampsia. Placenta 2002;23:359–372.
   PubMed Web of Science ®Google Scholar
• Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003;102:181–192.
   PubMed Web of Science ®Google Scholar
• Kaufmann P, Black S, Huppertz B. Endovascular tropho-blast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003;69:1–7.
   Google Scholar
• Myatt L. Role of placenta in preeclampsia. Endocrine 2002;19:103–111.
   PubMed Web of Science ®Google Scholar
• Brosens JJ, Pijnenborg R, Brosens IA. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstet Gynecol 2002;187:1416–1423.
   Google Scholar
• Norwitz ER, Hsu CD, Repke JT. Acute complications of preeclampsia. Clin Obstet Gynecol 2002;45:308–329.
   PubMed Web of Science ®Google Scholar
• Martin JN, Jr., Rinehart BK, May WL, et al. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol 1999;180:1373–1384.
   PubMed Web of Science ®Google Scholar
• Robertson WB, Brosens I, Dixon G. Maternal uterine vascular lesions in the hypertensive complications of pregnancy. Perspect Nephrol Hypertens 1976;5:115–127.
   PubMedGoogle Scholar
• Pijnenborg R, Anthony J, Davey DA, et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991;98:648–655.
   PubMedGoogle Scholar
• Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Chin Invest 1997;99:2152–2164.
   Google Scholar
• Zhou Y, Fisher SJ, Janatpour M, et al. Human cytotropho-blasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Chin Invest 1997;99:2139–2151.
   PubMed Web of Science ®Google Scholar
• Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998;16:5–15.
   PubMedGoogle Scholar
• Hunter CA Jr, Howard WF. A pressor substance (hyster-otonin) occurring in toxemia. Am J Obstet Gynecol 1960;79:838–846.
   PubMed Web of Science ®Google Scholar
• Zuspan FP. Catecholamines. Their role in pregnancy and the development of pregnancy-induced hypertension. J Reprod Med 1979;23:143–150.
   Google Scholar
• Neale D, Demasio K, Illuzi J, et al. Maternal serum of women with pre-eclampsia reduces trophoblast cell viability: evidence for an increased sensitivity to Fas-mediated apoptosis. J Matern Fetal Neonatal Med 2003;13:39–44.
   PubMedGoogle Scholar
• Pirani BB, MacGillivray I. The effect of plasma retransfusion on the blood pressure in the puerperium. Am J Obstet Gynecol 1975;121:221–226.
   PubMed Web of Science ®Google Scholar
• Krege JH, Katz VL. A proposed relationship between vasopressinase altered vasopressin and preeclampsia. Med Hypotheses 1990;31:283–287.
   PubMed Web of Science ®Google Scholar
• McKinney ET, Shouri R, Hunt RS, et al. Plasma, urinary, and salivary 8-epi-prostaglandin f2alpha levels in normoten-sive and preeclamptic pregnancies. Am J Obstet Gynecol 2000;183:874–877.
   PubMed Web of Science ®Google Scholar
• Pedersen EB, Aalkjaer C, Christensen NJ, et al. Renin, angiotensin II, aldosterone, catecholamines, prostaglandins and vasopressin. The importance of pressor and depressor factors for hypertension in pregnancy. Scand J Chin Lab Invest Suppl 1984;169:48–56.
   PubMedGoogle Scholar
• Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 1997;37:240–249.
   PubMed Web of Science ®Google Scholar
• Granger JP, Alexander BT, Llinas MT, et al. Pathophysiol-ogy of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 2002;9:147–160.
   PubMed Web of Science ®Google Scholar
• Zhou Y, McMaster M, Woo K, et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe pree-clampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 2002;160:1405–1423.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Bellingard V, Feng KT, et al. Human cytotropho-blasts promote endothelial survival and vascular remodeling through secretion of Ang2, P1GF, and VEGF-C. Dev Biol 2003;263:114–125.
   PubMed Web of Science ®Google Scholar
• Ahmed A, Perkins J. Angiogenesis and intrauterine growth restriction. Baillieres Best Pract Res Chin Obstet Gynaecol 2000;14:981–998.
   PubMed Web of Science ®Google Scholar
• Charnock-Jones DS, Burton GJ. Placental vascular morpho-genesis. Baillieres Best Pract Res Chin Obstet Gynaecol 2000;14:953–968.
   PubMed Web of Science ®Google Scholar
• Ong S, Lash G, Baker PN. Angiogenesis and placental growth in normal and compromised pregnancies. Baillieres Best Pract Res Chin Obstet Gynaecol 2000;14:969–980.
   Google Scholar
• Torry DS, Mukherjea D, Arroyo J, et al. Expression and function of placenta growth factor: implications for abnormal placentation. J Soc Gynecol Invest 2003;10:178–188.
   PubMedGoogle Scholar
• Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9:669–676.
   Google Scholar
• Gerber HP, McMurtrey A, Kowalski J, et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal trans-duction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 1998;273:30336–30343.
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Moons L, Luttun A, et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001;7:575–583.
   PubMed Web of Science ®Google Scholar
• Mac Gabhann F, Popel AS. Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells. Am J Physiol Heart Circ Physiol 2003;286:H153–H164.
   Web of Science ®Google Scholar
• Hiratsuka S, Maru Y, Okada A, et al. Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis. Cancer Res 2001611207–1213.
   Google Scholar
• Athanassiades A, Lala PK. Role of placenta growth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasiveness. Placenta 1998;19:465–473.
   PubMed Web of Science ®Google Scholar
• Cheung CY. Vascular endothelial growth factor: possible role in fetal development and placental function. J Soc Gynecol Invest 1997;4:169–177.
   PubMedGoogle Scholar
• Clark DE, Smith SK, He Y, et al. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod 1998;59:1540–1548.
   PubMed Web of Science ®Google Scholar
• Desai J, Holt-Shore V, Torry RJ, et al. Signal transduction and biological function of placenta growth factor in primary human trophoblast. Biol Reprod 1999;60:887–892.
   PubMed Web of Science ®Google Scholar
• Hayman R, Brockelsby J, Kenny L, et al. Preeclampsia: the endothelium, circulating factor(s) and vascular endothelial growth factor. J Soc Gynecol Invest 1999;6:3–10.
   PubMedGoogle Scholar
• Hornig C, Barleon B, Ahmad S, et al. Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids. Lab Invest 2000;80:443–454.
   PubMed Web of Science ®Google Scholar
• Kendall RL,, Wang G, Thomas KA. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun 1996;226:324–328.
   PubMed Web of Science ®Google Scholar
• Kupferminc MJ, Daniel Y, Englender T, et al. Vascular endothelial growth factor is increased in patients with preeclampsia. Am J Reprod Immunol 1997;38:302–306.
   PubMed Web of Science ®Google Scholar
• Lash GE, Cartwright JE, Whitley GS, et al. The effects of angiogenic growth factors on extravillous trophoblast inva-sion and motility. Placenta 1999;20:661–667.
   PubMed Web of Science ®Google Scholar
• Lyall F, Greer IA. The vascular endothelium in normal pregnancy and pre-eclampsia. Rev Reprod 1996;1:107–116.
   PubMedGoogle Scholar
• Lyall F, Greer IA, Boswell F, et al. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia. Br J Obstet Gynaecol 1997;104:223–228.
   PubMedGoogle Scholar
• Reuvekamp A, Velsing-Aarts FV, Poulina IE, et al. Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol 1999;106:1019–1022.
   PubMedGoogle Scholar
• Reynolds LP, Redmer DA. Utero-placental vascular devel-opment and placental function. J Anim Sci 1995;73:1839–1851.
   PubMed Web of Science ®Google Scholar
• Schlembach D, Beinder E. Angiogenic factors in preeclamp-sia. J Soc Gynecol Invest 2003;10:316A.
   Google Scholar
• Taylor RN, de Groot CJ, Cho YK, et al. Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia. Semin Reprod Endocrinol 1998;16:17–31.
   PubMedGoogle Scholar
• Taylor RN, Grimwood J, Taylor RS, et al. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003;188:177–182.
   PubMed Web of Science ®Google Scholar
• Tidwell SC, Ho HN, Chiu WH, et al. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 2001;184:1267–1272.
   PubMed Web of Science ®Google Scholar
• Torry DS, Wang HS, Wang TH, et al. Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol 1998;179:1539–1544.
   PubMed Web of Science ®Google Scholar
• Torry DS, Ahn H, Barnes EL, et al. Placenta growth factor: potential role in pregnancy. Am J Reprod Immunol 1999;41:79–85.
   PubMed Web of Science ®Google Scholar
• Tsatsaris V, Goffm F, Munaut C, et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Chin Endocrinol Metab 2003;88:5555–5563.
   PubMed Web of Science ®Google Scholar
• Vuorela P, Hatva E, Lymboussaki A, et al. Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod 1997;56:489–494.
   PubMed Web of Science ®Google Scholar
• Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Chin Invest 2003;111:649–658.
   PubMed Web of Science ®Google Scholar
• Koga K, Osuga Y, Yoshino 0, et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Chin Endocrinol Metab 2003;88: 2348–2351.
   Google Scholar
• Chaiworapongsa T, Romera R, Espinoza J, et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol 2004;190:1541–47.
   PubMed Web of Science ®Google Scholar
• Livingston JC, Chin R, Haddad B, et al. Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. Am J Obstet Gynecol 2000;183:1554–1557.
   PubMed Web of Science ®Google Scholar
• Kincaid-Smith P. The renal lesion of preeclampsia revisited. Am J Kidney Dis 1991;17:144–148.
   PubMed Web of Science ®Google Scholar
• Hill PA, Fairley KF, Kincaid-Smith P, et al. Morphologic changes in the renal glomerulus and the juxtaglomerular apparatus in humanpreeclampsia. J Pathol 1988;156:291–303.
   Google Scholar
• Gaber LW, Spargo BH, Lindheimer MD. Renal pathology in pre-eclampsia. Baillieres Chin Obstet Gynaecol 1987;1:971–995.
   PubMed Web of Science ®Google Scholar
• Strevens H, Wide-Swensson D, Hansen A, et al. Glomerular endotheliosis in normal pregnancy and pre-eclampsia. BJOG 2003;110:831–836.
   PubMed Web of Science ®Google Scholar
• Sibai BM, Ewell M, Levine RJ, et al. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 1997;177:1003–1010.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672–683.
   PubMed Web of Science ®Google Scholar
• Gant NF, Chand S, Whalley PJ, et al. The nature of pressor responsiveness to angiotensin II in human pregnancy. Obstet Gynecol 1974;43:854.
   PubMed Web of Science ®Google Scholar
• Gant NF, Chand S, Worley RJ, et al. A clinical test useful for predicting the development of acute hypertension in preg-nancy. Am J Obstet Gynecol 1974;120:1–7.
   PubMed Web of Science ®Google Scholar
• Harrington KF, Campbell S, Bewley S, et al. Doppler velocimetry studies of the uterine artery in the early prediction of pre-eclampsia and intra-uterine growth retar-dation. Eur J Obstet Gynecol Reprod Biol 1991;42 Suppl: S14–S20.
   Google Scholar
• Kurmanavicius J, Florio I, Wisser J, et al. Reference resistance indices of the umbilical, fetal middle cerebral and uterine arteries at 24-42 weeks of gestation. Ultrasound Obstet Gynecol 1997;10:112–120.
   PubMed Web of Science ®Google Scholar
• Bower S, Schuchter K, Campbell S. Doppler ultrasound screening as part of routine antenatal scanning: prediction of pre-eclampsia and intrauterine growth retardation. Br J Obstet Gynaecol 1993;100:989–994.
   Google Scholar
• Adamson SL, Morrow RJ, Bascom PA, et al. Effect of placental resistance, arterial diameter, and blood pressure on the uterine arterial velocity waveform: a computer modeling approach. Ultrasound Med Biol 1989;15:437–442.
   PubMed Web of Science ®Google Scholar
• Ochi H, Suginami H, Matsubara K, et al. Micro-bead embolization of uterine spiral arteries and changes in uterine arterial flow velocity waveforms in the pregnant ewe. Ultrasound Obstet Gynecol 1995;6:272–276.
   PubMed Web of Science ®Google Scholar
• Ochi H, Matsubara K, Kusanagi Y, et al. Significance of a diastolic notch in the uterine artery flow velocity waveform induced by uterine embolisation in the pregnant ewe. Br J Obstet Gynaecol 1998;105:1118–1121.
   PubMedGoogle Scholar
• Talbert DG. Uterine flow velocity waveform shape as an indicator of maternal and placental development failure mechanisms: a model-based synthesizing approach. Ultra-sound Obstet Gynecol 1995;6:261–271.
   PubMed Web of Science ®Google Scholar
• Lin S, Shimizu I, Suehara N, et al. Uterine artery Doppler velocimetry in relation to trophoblast migration into the myometrium of the placental bed. Obstet Gynecol 1995;85:760–765.
   PubMed Web of Science ®Google Scholar
• Olofsson P, Laurini RN, Marsal K. A high uterine artery pulsatility index reflects a defective development of placental bed spiral arteries in pregnancies complicated by hyperten-sion and fetal growth retardation. Eur J Obstet Gynecol Reprod Biol 1993;49:161–168.
   Google Scholar
• Campbell S, Black RS, Lees CC, et al. Doppler ultrasound of the maternal uterine arteries: disappearance of abnormal waveforms and relation to birthweight and pregnancy outcome. Acta Obstet Gynecol Scand 2000;79:631–634.
   PubMed Web of Science ®Google Scholar
• Albaiges G, Missfelder-Lobos H, Lees C, et al. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation. Obstet Gynecol 2000;96:559–564.
   PubMed Web of Science ®Google Scholar
• Chappell L, Bewley S. Pre-eclamptic toxaemia: the role of uterine artery Doppler. Br J Obstet Gynaecol 1998;105:379–382.
   PubMedGoogle Scholar
• Zimmermann P, Eirio V, Koskinen J, et al. Doppler assessment of the uterine and uteroplacental circulation in the second trimester in pregnancies at high risk for pre-eclampsia and/or intrauterine growth retardation: compar-ison and correlation between different Doppler parameters. Ultrasound Obstet Gynecol 1997;9:330–338.
   PubMed Web of Science ®Google Scholar
• Todros T, Ferrazzi E, Arduini D, et al. Performance of Doppler ultrasonography as a screening test in low risk pregnancies: results of a multicentric study. J Ultrasound Med 1995;14:343–348.
   PubMed Web of Science ®Google Scholar
• North RA, Ferrier C, Long D, et al. Uterine artery Doppler flow velocity waveforms in the second trimester for the prediction of preeclampsia and fetal growth retardation. Obstet Gynecol 1994;83:378–386.
   PubMed Web of Science ®Google Scholar
• Schulman H. The clinical implications of Doppler ultra-sound analysis of the uterine and umbilical arteries. Am J Obstet Gynecol 1987;156:889–893.
   PubMed Web of Science ®Google Scholar
• Fleischer A, Schulman H, Farmakides G, et al. Uterine artery Doppler velocimetry in pregnant women with hyper-tension. Am J Obstet Gynecol 1986;154:806–813.
   PubMed Web of Science ®Google Scholar
• Papageorghiou AT, Yu CK, Bindra R, et al. Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 2001;18:441–449.
   PubMed Web of Science ®Google Scholar
• Ahmed A, Li XF, Dunk C, et al. Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta. Growth Factors 1995;12:235–243.
   PubMed Web of Science ®Google Scholar
• Charnock-Jones DS, Sharkey AM, Boocock CA, et al. Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells. Biol Reprod 1994;51:524–530.
   Google Scholar
• Clark DE, Smith SK, Sharkey AM, et al. Localization of VEGF and expression of its receptors fit and KDR in human placenta throughout pregnancy. Hum Reprod 1996;11:1090–1098.
   PubMed Web of Science ®Google Scholar
• Khaliq A, Dunk C, Jiang J, et al. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction. Lab Invest 1999;79:151–170.
   PubMed Web of Science ®Google Scholar
• Lash GE, Taylor CM, Trew AJ, et al. Vascular endothelial growth factor and placental growth factor release in cultured trophoblast cells under different oxygen tensions. Growth Factors 2002;20:189–196.
   PubMed Web of Science ®Google Scholar
• Shore VH, Wang TH, Wang CL, et al. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 1997;18:657–665.
   PubMed Web of Science ®Google Scholar
• Helske S, Vuorela P, Carpen 0, et al. Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies. Mol Hum Reprod 2001;7: 205–210.
   Google Scholar
• Kumazaki K, Nakayama M, Suehara N, et al. Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions. Hum Pathol 2002;33:1069–1077.
   PubMed Web of Science ®Google Scholar
• Trollmann R, Amann K, Schoof E, et al. Hypoxia activates the human placental vascular endothelial growth factor system in vitro and in vivo: up-regulation of vascular endothelial growth factor in clinically relevant hypoxic ischemia in birth asphyxia. Am J Obstet Gynecol 2003;188:517–523.
   PubMed Web of Science ®Google Scholar
• Ahmed A, Dunk C, Kniss D, et al. Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells. Lab Invest 1997;76:779–791.
   PubMed Web of Science ®Google Scholar
• Athanassiades A, Hamilton GS, Lola PK. Vascular endothe-lial growth factor stimulates proliferation but not migration or invasiveness in human extravillous trophoblast. Biol Reprod 1998;59:643–654.
   Google Scholar
• Benirschke K, Kaufmann P. Pathology of the human placenta. 4th ed. New York: Springer; 2000. pp 116–154.
   Google Scholar
• Kingdom JC, Kaufmann P. Oxygen and placental vascular development. Adv Exp Med Biol 1999;474:259–275.
   PubMed Web of Science ®Google Scholar
• Todros T, Sciarrone A, Piccoli E, et al. Umbilical Doppler waveforms and placental villous angiogenesis in pregnancies complicated by fetal growth restriction. Obstet Gynecol 1999;93:499–503.
   PubMed Web of Science ®Google Scholar
• Kingdom J, Huppertz B, Seaward G, et al. Development of the placental villous tree and its consequences for fetal growth. Eur J Obstet Gynecol Reprod Biol 2000;92:35–43.
   PubMed Web of Science ®Google Scholar
• Geva E, Ginzinger DG, Zaloudek CJ, et al. Human placental vascular development: vasculogenic and angiogenic (branch-ing and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. J Chin Endocrinol Metab 2002;87:4213–4224.
   PubMed Web of Science ®Google Scholar
• Mayhew TM. Fetoplacental angiogenesis during gestation is biphasic, longitudinal and occurs by proliferation and remodelling of vascular endothelial cells. Placenta 2002;23:742–750.
   PubMed Web of Science ®Google Scholar
• Kaufmann P, Luckhardt M, Schweikhart G, et al. Cross-sectional features and three-dimensional structure of human placental villi. Placenta 1987;8:235–247.
   PubMed Web of Science ®Google Scholar
• Jackson MR, Walsh AJ, Morrow RJ, et al. Reduced placental villous tree elaboration in small-for-gestational-age pregnan-cies: relationship with umbilical artery Doppler waveforms. Am J Obstet Gynecol 1995;172:518–525.
   PubMed Web of Science ®Google Scholar
• Krebs C, Macara LM, Leiser R, et al. Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree. Am J Obstet Gynecol 1996;175:1534–1542.
   PubMed Web of Science ®Google Scholar
• Boyle JW, L,otgering FK, Longo LD. Acute embolization of the uteroplacental circulation: uterine blood flow and placental CO diffusing capacity. J Dev Physiol 1984;6:377–386.
   Google Scholar
• Brar HS, Medearis AL, DeVore GR, et al. A comparative study of fetal umbilical velocimetry with continuous- and pulsed-wave Doppler ultrasonography in high-risk pregnan-cies: relationship to outcome. Am J Obstet Gynecol 1989;160:375–378.
   PubMed Web of Science ®Google Scholar
• Trudinger BJ, Cook CM. Doppler umbilical and uterine flow waveforms in severe pregnancy hypertension. Br J Obstet Gynaecol 1990;97:142–148.
   PubMedGoogle Scholar
• Trudinger BJ, Cook CM, Giles WB, et al. Fetal umbilical artery velocity waveforms and subsequent neonatal outcome. Br J Obstet Gynaecol 1991;98:378–384.
   PubMedGoogle Scholar
• Kuzuya M, Ramos MA, Kanda S, et al. VEGF protects against oxidized LDL toxicity to endothelial cells by an intracellular glutathione-dependent mechanism through the KDR receptor. Arterioscler Thromb Vasc Biol 2001;21:765–770.
   PubMed Web of Science ®Google Scholar
• Horowitz JR, Rivard A, van der ZR, et al. Vascular endothelial growth factor/vascular permeability factor pro-duces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium. Arterios-cler Thromb Vasc Biol 1997;17:2793–2800.
   PubMed Web of Science ®Google Scholar
• Polliotti BM, Fry AG, Saller DN, et al. Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia. Obstet Gynecol 2003;101:1266–1274.
   PubMed Web of Science ®Google Scholar
• Su YN, Lee CN, Cheng WF, et al. Decreased maternal serum placenta growth factor in early second trimester and preeclampsia. Obstet Gynecol 2001;97:898–904.
   PubMed Web of Science ®Google Scholar
• Tjoa ML,, van Vugt JM, Mulders MA, et al. Plasma placenta growth factor levels in midtrimester pregnancies. Obstet Gynecol 2001;98:600–607.
   PubMed Web of Science ®Google Scholar
• Yang S, Toy K, Ingle G, et al. Vascular endothelial growth factor-induced genes in human umbilical vein endothelial cells: relative roles of KDR and Flt-1 receptors. Arterioscler Thromb Vasc Biol 200222:1797-1803.
   PubMed Web of Science ®Google Scholar
• Kroll J, Waltenberger J. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem Biophys Res Commun 1998;252:743–746.
   PubMed Web of Science ®Google Scholar
• Kroll J, Waltenberger J. A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells. Biochem Biophys Res Commun 1999;265:636–639.
   PubMed Web of Science ®Google Scholar
• Tsurumi Y, Murohara T, Krasinski K, et al. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med 1997;3:879–886.
   PubMed Web of Science ®Google Scholar
• He H, Venema VJ, Gu X, et al. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J Biol Chem 1999;274:25130–25135.
   PubMed Web of Science ®Google Scholar
• Gliki G, Abu-Ghazaleh R, Jezequel S, et al. Vascular endothelial growth factor-induced prostacyclin production is mediated by a protein kinase C (PKC)-dependent activation of extracellular signal-regulated protein kinases 1 and 2 involving PKC-delta and by mobilization of intracel-lular Ca [2] + . Biochem J 2001;353:503–512.
   PubMed Web of Science ®Google Scholar
• Sugimoto H, Hamano Y, Charytan D, et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 2003;278:12605–12608.
   PubMed Web of Science ®Google Scholar
• Ostendorf T, Kunter U, Eimer F, et al. VEGF(165) mediates glomerular endothelial repair. J Clin Invest 1999;104:913–923.
   PubMed Web of Science ®Google Scholar
• Kabbinavar F, Hurwitz HI, Fehrenbacher L, et al. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. J Clin Oncol 2003;21:60–65.
   PubMed Web of Science ®Google Scholar
• Bayhan G, Atamer Y, Atamer A, et al. Significance of changes in lipid peroxides and antioxidant enzyme activities in pregnant women with preeclampsia and eclampsia. Clin Exp Obstet Gynecol 2000;27:142–146.
   PubMedGoogle Scholar
• Mutlu-Turkoglu U, Aykac-Toker G, Ibrahimoglu L, et al. Plasma nitric oxide metabolites and lipid peroxide levels in preeclamptic pregnant women before and after delivery. Gynecol Obstet Invest 1999;48:247–250.
   PubMed Web of Science ®Google Scholar
• Winkler K, Wetzka B, Hoffmann MM, et al. Triglyceride-rich lipoproteins are associated with hypertension in pre-eclampsia. J Clin Endocrinol Metab 2003;88:1162–1166.
   PubMed Web of Science ®Google Scholar
• Takacs P, Kauma SW, Sholley MM, et al. Increased circulating lipid peroxides in severe preeclampsia activate NF-kappaB and upregulate ICAM-1 in vascular endothelial cells. FASEB J 2001;15:279–281.
   PubMed Web of Science ®Google Scholar
• Hubel CA. Oxidative stress in the pathogenesis of pre-eclampsia. Proc Soc Exp Biol Med 1999;222:222–235.
   PubMed Web of Science ®Google Scholar
• Vaughan JE, Walsh SW. Oxidative stress reproduces placental abnormalities of preeclampsia. Hypertens Preg-nancy 2002;21:205–223.
   PubMed Web of Science ®Google Scholar
• Myatt L, Kossenjans W, Sahay R, et al. Oxidative stress causes vascular dysfunction in the placenta. J Matem Fetal Med 2000;9:79–82.
   PubMedGoogle Scholar
• Walsh SW, Vaughan JE, Wang Y, et al. Placental isoprostane is significantly increased in preeclampsia. FASEB J 2000;14:1289–1296.
   PubMed Web of Science ®Google Scholar
• Roes EM, Raijmakers MT, Zusterzeel PL, et al. Deficient detoxifying capacity in the pathophysiology of preeclampsia. Med Hypotheses 2000;55:415–418.
   PubMed Web of Science ®Google Scholar
• Sagol S, Ozkinay E, Ozsener S. Impaired antioxidant activity in women with pre-eclampsia. Int J Gynaecol Obstet 1999;64:121–127.
   PubMed Web of Science ®Google Scholar
• Kharb S. Total free radical trapping antioxidant potential in pre-eclampsia. Int J Gynaecol Obstet 2000;69:23–26.
   PubMed Web of Science ®Google Scholar
• Chappell LC, Seed PT, Briley A, et al. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002;187:127–136.
   PubMed Web of Science ®Google Scholar
• Gratacos E, Casals E, Gomez 0, et al. Increased suscept-ibility to low density lipoprotein oxidation in women with a history of pre-eclampsia. BJOG 2003;110:400–404.
   Google Scholar
• Ozan H, Ilcol Y, Kimya Y, et al. Plasma anti-oxidant status and lipid profile in non-gravida women with a history of pre-eclampsia. J Obstet Gynaecol Res 2002;28:274–279.
   PubMed Web of Science ®Google Scholar
• De Bandt M, Ben Mahdi MH, 011ivier V, et al. Blockade of vascular endothelial growth factor receptor I (VEGF-RI), but not VEGF-RII, suppresses joint destruction in the K/BxN model of rheumatoid arthritis. J Immunol 2003;171:4853–4859.
   Google Scholar